The Improved Experience You’ve Been Waiting For! Discover the refreshed menu, enjoy the custom dashboard, and make use of the powerful stock screener to enhance your investment approach. Explore Now

BLUSD:PA BNP PARIBAS EASY - ECPI Global ESG Blue Economy UCITS ETF USD Capitalisation

USD 12.03 -0.01 ( -0.057305)
Icon

BNP PARIBAS EASY - ECPI Global ESG Blue Economy UCITS ETF USD Capitalisation (BLUSD:PA) Stock Analysis and Price Targets

ETF | Others | PA
Target Add to Watchlist
Take a Tour
stockTargetAdvisor

N/A

Average Analyst
Rating
stockTargetAdvisor

N/A

Top Analyst
Rating
stockTargetAdvisor

Neutral

Stock Target Advisor
Analysis
stockTargetAdvisor

N/A

Average User
Rating

USD 12.03

-0.01 (-0.06)%

N/A

N/A

USD -1.00

N/A
Icon

BLUSD:PA

BNP PARIBAS EASY - ECPI Global ESG Blue Economy UCITS ETF USD Capitalisation (USD)
ETF | PA
USD 12.03
-0.01 ( -0.057305)
Watchlist

BNP PARIBAS EASY - ECPI Global ESG Blue Economy UCITS ETF USD Capitalisation (BLUSD:PA) Stock Forecast

USD -1.00

Based on the BNP PARIBAS EASY - ECPI Global ESG Blue Economy UCITS ETF USD Capitalisation stock forecast from 0 analysts, the average analyst target price for BNP PARIBAS EASY - ECPI Global ESG Blue Economy UCITS ETF USD Capitalisation is not available over the next 12 months. BNP PARIBAS EASY - ECPI Global ESG Blue Economy UCITS ETF USD Capitalisation’s average analyst rating is not available. Stock Target Advisor’s own stock analysis of BNP PARIBAS EASY - ECPI Global ESG Blue Economy UCITS ETF USD Capitalisation is Neutral, which is based on 0 positive signals and 0 negative signals. At the last closing, BNP PARIBAS EASY - ECPI Global ESG Blue Economy UCITS ETF USD Capitalisation’s stock price was USD 12.03. BNP PARIBAS EASY - ECPI Global ESG Blue Economy UCITS ETF USD Capitalisation’s stock price has changed by -1.93% over the past week, +5.29% over the past month and +20.39% over the last year.

Analyst Ratings

Target Price Action Rating Action Analyst Rating Price Date
Stock Target Advisor

Stock Target Advisor's Analysis

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

Icon
What to like

Icon
What not to like